The Carlyle Group agreed to invest in TriNetX, a global health research network optimizing clinical research. Financial terms were not disclosed. "Our goal is to be on the desktop of every healthcare researcher in the world. To accomplish this we need to continue to develop solutions to support clinical research at our healthcare organizations and bring more global data and technologies such as AI, machine learning and analytics to researchers so that they can ask more questions and generate more real-world evidence. Carlyle's investment accelerates our growth plans and will shorten the time it takes to turn our vision into reality," Gadi Lachman, TriNetX CEO.